Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…
HOME > TOP STORIES
TOP STORIES
-
BUSINESS Gene Therapy Deaths Spur Strategic Rethink among Biotechs, Merck Exec Notes Investor Caution
July 30, 2025
-
REGULATORY Post-Marketing Oversight and Regulatory Reviews Must Work as One, Says New MHLW Safety Chief
July 29, 2025
-
REGULATORY Astellas Employee Did Not Appeal, Prison Sentence Finalized in China
July 29, 2025
-
COMMENTARY Pharmaceutical Policy at a Crossroad amid Political Upheaval in Japan
July 28, 2025
-
REGULATORY MSD’s 21-Valent Pneumococcal Shot Nears Japan Approval; Male Use of Silgard 9 Cleared
July 25, 2025
-
BUSINESS Chugai to Defer Domestic Supply of Elevidys amid Safety Review
July 25, 2025
-
REGULATORY Santen’s Glaucoma Drug, Taisho’s Insomnia Med Up for Panel Review on July 31
July 25, 2025
-
REGULATORY MHLW Plans to Ease Clinical Trial Ad Rules, Eyes Notification by March-End
July 24, 2025
-
BUSINESS Towa Launches Task Force to Tackle Nitrosamine Impurities, Share Solutions with Peers
July 24, 2025
-
REGULATORY New MHLW Drug Review Chief Aims to Dispel “Barrier” Perception, Pledges Active Engagement with Industry
July 23, 2025
-
REGULATORY Healthcare Stakeholders Weigh Fallout after Ruling Bloc’s Election Setback
July 23, 2025
-
REGULATORY Japan’s Ruling Bloc Routed in Upper House Poll; Takemi to Retire, Furukawa, Kamayachi, and Honda Secure Seats
July 22, 2025
-
BUSINESS JRI Urges Reforms in Pricing and Reimbursement to Support Regenerative Medicine Ecosystem
July 18, 2025
-
REGULATORY Japan Begins FY2026 CEA Reform Talks, Re-Designation after Market Expansion Up for Debate
July 17, 2025
-
REGULATORY Astellas Employee Sentenced to 3.5 Years in China for Spying
July 17, 2025
-
ORGANIZATION Industry Calls for More Tailored Govt Support on Drug Loss Product Development
July 16, 2025
-
BUSINESS Global Pharma Market Surges 9% to US$1.6 Trillion in 2024, Ozempic Overtakes Humira: IQVIA
July 16, 2025
-
BUSINESS Asahi Kasei Sharpens Acquisition Focus in Pharma Biz as Envarsus LOE Looms
July 15, 2025
-
REGULATORY Japan’s Major Parties Outline Various Drug Policy Visions Ahead of Upper House Poll
July 14, 2025
-
BUSINESS Espha President Signals Move Toward Novel Drug Development amid Group Shift
July 11, 2025
ページ
As Japan approaches the Fiscal System Council’s “autumn recommendation,” a notable shift is taking shape. The Ministry of Finance (MOF),…
Japan is considering a new approach to its “special” market expansion re-pricing that would exclude drug sales tied to private…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…